HOXA5 and non-small cell lung carcinoma: As for its upstream modulator, only HOXA5 has been reported to bind to the promoter of LINC00312 and upregulate the expression of LINC00312, leading to increased apoptosis in nonsmall cell lung cancer (NSCLC) [18].